User login
Community Oncology and Journal of Supportive Oncology: 8th Annual Community Oncology Journal's Oncology Practice Summit
New therapies bolster the melanoma armamentarium
Community Oncology Editor Dr. Jame Abraham spoke with Dr. Michael Postow at the Oncology Practice Summit in Las Vegas about new immuno- and targeted therapies for melanoma, their side effects, and early phase studies of emerging therapies.
The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology, and The Oncology Report.
Community Oncology Editor Dr. Jame Abraham spoke with Dr. Michael Postow at the Oncology Practice Summit in Las Vegas about new immuno- and targeted therapies for melanoma, their side effects, and early phase studies of emerging therapies.
The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology, and The Oncology Report.
Community Oncology Editor Dr. Jame Abraham spoke with Dr. Michael Postow at the Oncology Practice Summit in Las Vegas about new immuno- and targeted therapies for melanoma, their side effects, and early phase studies of emerging therapies.
The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology, and The Oncology Report.